Early warrants call expected to bring in $10.4M for InVivo

05/7/2013 | MassDevice.com (Boston)

InVivo Therapeutics is poised to obtain $10.4 million from a call for early exercise of warrants it released to investors in 2010. The call could "eliminate a major impediment towards the up-listing of the company's stock to a national securities exchange," the spinal device company said in a release.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX